Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPPI
4676
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $373K | ﹤0.01% |
389,020
-337,139
| -46% | -$333K |
|
4677
iShares Global Tech ETF
IXN
$9.64B
| $373K | ﹤0.01% |
6,001
-8,399
| -58% | -$476K |
|
|
KLR
4678
DELISTED
Kaleyra, Inc.
KLR
| $373K | ﹤0.01% |
+55,337
| New | +$147K |
|
4679
Invesco Food & Beverage ETF
PBJ
$90.9M
| $373K | ﹤0.01% |
8,201
+1,656
| +25% | +$76.7K |
|
4680
iShares Expanded Tech-Software Sector ETF
IGV
$15.2B
| $372K | ﹤0.01% |
+5,380
| New | +$338K |
|
4681
nCino
NCNO
$2.47B
| $372K | ﹤0.01% |
12,336
-17,253
| -58% | -$439K |
|
4682
CALL
Pliant Therapeutics
PLRX
$71.2M
| $371K | ﹤0.01% |
+20,500
| New | +$485K |
|
4683
Landstar System
LSTR
$6.17B
| $371K | ﹤0.01% |
1,926
-10,804
| -85% | -$1.95M |
|
4684
CALL
Grab
GRAB
$14.7B
| $371K | ﹤0.01% |
+161,784
| New | +$504K |
|
4685
Quanex
NX
$904M
| $370K | ﹤0.01% |
+13,786
| New | +$307K |
|
4686
Greif Class B
GEF.B
$4.09B
| $370K | ﹤0.01% |
4,789
-4,355
| -48% | -$332K |
|
|
BFZ
4687
DELISTED
BlackRock CA Municipal Income Trust
BFZ
| $369K | ﹤0.01% |
31,134
-26,536
| -46% | -$312K |
|
4688
CALL
LiveWire Group Warrants
LVWR.WS
$5.7M
| $369K | ﹤0.01% |
600,000
| – | – |
|
4689
ICU Medical
ICUI
$4.38B
| $368K | ﹤0.01% |
2,066
-4,798
| -70% | -$880K |
|
4690
PUT
C.H. Robinson
CHRW
$17.7B
| $368K | ﹤0.01% |
+3,900
| New | +$377K |
|
4691
Tyra Biosciences
TYRA
$1.56B
| $368K | ﹤0.01% |
21,591
+8,116
| +60% | +$118K |
|
4692
Noodles & Co
NDLS
$88.1M
| $365K | ﹤0.01% |
+13,490
| New | +$441K |
|
|
NBXG
4693
Neuberger Next Generation Connectivity Fund Inc
NBXG
$1.2B
| $364K | ﹤0.01% |
33,378
-65,586
| -66% | -$663K |
|
4694
First Majestic Silver
AG
$10.7B
| $364K | ﹤0.01% |
64,434
-1,239,081
| -95% | -$7.94M |
|
4695
Alector
ALEC
$267M
| $363K | ﹤0.01% |
60,465
+41,385
| +217% | +$289K |
|
|
VMRK
4696
PUT
Vivmark Residential
VMRK
$26.1B
| $363K | ﹤0.01% |
+5,500
| New | +$344K |
|
|
HONE
4697
DELISTED
HarborOne Bancorp
HONE
| $362K | ﹤0.01% |
41,746
+2,784
| +7% | +$26.6K |
|
|
IMMP
4698
Immutep
IMMP
$56.1M
| $361K | ﹤0.01% |
171,158
-358,980
| -68% | -$672K |
|
4699
Anterix
ATEX
$1.86B
| $360K | ﹤0.01% |
+11,362
| New | +$367K |
|
4700
Enlight Renewable Energy
ENLT
$11.3B
| $359K | ﹤0.01% |
20,245
-15,375
| -43% | -$272K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.